51. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages
- Author
-
Montgomery Munby, Chika Kawaguchi, Satoshi Gondaira, Hidetomo Iwano, Hirofumi Sawa, Michihito Sasaki, Yumie Matsuda, Tomohiro Nakamura, Yutaka Tamura, Masaru Usui, Hidetoshi Higuchi, Tomohito Iwasaki, Keisuke Nakamura, Jumpei Fujiki, Takaaki Furusawa, and Yusei Shiokura
- Subjects
Veterinary medicine ,Phage therapy ,viruses ,medicine.medical_treatment ,Immunology ,Myoviridae ,Context (language use) ,Genome, Viral ,medicine.disease_cause ,Microbiology ,Host Specificity ,Bacteriophage ,03 medical and health sciences ,Antibiotic resistance ,Virology ,Drug Resistance, Multiple, Bacterial ,medicine ,Bacteriophages ,Pseudomonas Infections ,Phage Therapy ,Phylogeny ,030304 developmental biology ,0303 health sciences ,biology ,030306 microbiology ,Pseudomonas aeruginosa ,Pseudomonas ,biology.organism_classification ,Anti-Bacterial Agents ,Lytic cycle ,DNA, Viral ,Pseudomonas Phages - Abstract
In recent years, antimicrobial-resistant Pseudomonas aeruginosa strains have increased in the veterinary field. Therefore, phage therapy has received significant attention as an approach for overcoming antimicrobial resistance. In this context, we isolated and characterized four Pseudomonas bacteriophages. Phylogenetic analysis showed that the isolated phages are novel Myoviridae Pbunavirus PB1-like phages with OR12 belonging to a different clade compared with the other three. These phages had distinct lytic activity against 22 P. aeruginosa veterinary isolates. The phage cocktail composed from the PB1-like phages clearly inhibited the occurrence of the phage-resistant variant, suggesting that these phages could be useful in phage therapy.
- Published
- 2020